DK0701438T3 - GABA'erg modulation af øjenvækst - Google Patents

GABA'erg modulation af øjenvækst

Info

Publication number: DK0701438T3
Authority: DK; Denmark
Prior art keywords: gaba; eye; antagonist; eye growth; ergic
Prior art date: 1993-04-30

Application number

DK94914915T

Other languages

English (en)

Inventor

Richard A Stone

Alan M Laties

Original Assignee

Univ Pennsylvania

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-30

Filing date

1994-04-26

Publication date

1999-11-22

1994-04-26 Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania

1999-11-22 Application granted granted Critical

1999-11-22 Publication of DK0701438T3 publication Critical patent/DK0701438T3/da

Links

229960003692 gamma aminobutyric acid Drugs 0.000 title 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title 1
239000005557 antagonist Substances 0.000 abstract 2
WBSMZVIMANOCNX-UHFFFAOYSA-N 3-amino-2-(4-chlorophenyl)-2-hydroxy-1-propanesulfonic acid Chemical group OS(=O)(=O)CC(O)(CN)C1=CC=C(Cl)C=C1 WBSMZVIMANOCNX-UHFFFAOYSA-N 0.000 abstract 1
239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Cosmetics (AREA)

DK94914915T 1993-04-30 1994-04-26 GABA'erg modulation af øjenvækst DK0701438T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/056,056 US5385939A (en)	1993-04-30	1993-04-30	GABA-ergic modulation of eye growth
PCT/US1994/004586 WO1994025018A1 (en)	1993-04-30	1994-04-26	Gaba-ergic modulation of eye growth

Publications (1)

Publication Number	Publication Date
DK0701438T3 true DK0701438T3 (da)	1999-11-22

Family

ID=22001878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94914915T DK0701438T3 (da)	1993-04-30	1994-04-26	GABA'erg modulation af øjenvækst

Country Status (12)

Country	Link
US (2)	US5385939A (da)
EP (1)	EP0701438B1 (da)
JP (1)	JP3720047B2 (da)
CN (1)	CN1096854C (da)
AT (1)	ATE181829T1 (da)
AU (1)	AU6713694A (da)
CA (1)	CA2160798C (da)
DE (1)	DE69419416T2 (da)
DK (1)	DK0701438T3 (da)
ES (1)	ES2136195T3 (da)
GR (1)	GR3031352T3 (da)
WO (1)	WO1994025018A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1336490C (en) *	1988-06-03	1995-08-01	Paul Michael Iuvone	Pharmacological treatment of ocular development
ATE147626T1 (de) *	1989-06-21	1997-02-15	Univ Pennsylvania	Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung
US5385939A (en) *	1993-04-30	1995-01-31	The Trustees Of The University Of Pennsylvania	GABA-ergic modulation of eye growth
EP1397132A4 (en) *	2001-05-25	2006-12-13	Valley Forge Pharmaceuticals I	OPHTHALMIC PIRENZEPINE GEL
US20040023952A1 (en) *	2001-06-20	2004-02-05	Leventhal Audie G.	Enhanced brain function by gaba-ergic stimulation
US20060264508A1 (en) *	2001-10-16	2006-11-23	Stone Richard A	Modulation of ocular growth and myopia by gaba drugs
US20060142249A1 (en) *	2002-06-28	2006-06-29	Wolfgang Froestl	Ophthalmic use
US6713497B1 (en)	2003-03-17	2004-03-30	Brookhaven Science Associates, Llc	Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
FI20075498A7 (fi)	2007-06-29	2008-12-30	Eero Castren	Menetelmä amblyopian hoitamiseksi masennuslääkkeillä
WO2017177262A1 (en) *	2016-04-11	2017-10-19	University Of Canberra	Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4865599A (en) *	1986-08-18	1989-09-12	Houston Biotechnology, Inc.	Ophthalmic compositions for treating nerve degeneration
GB8728483D0 (en) *	1987-12-04	1988-01-13	Ciba Geigy Ag	Chemical compounds
CA1336490C (en) *	1988-06-03	1995-08-01	Paul Michael Iuvone	Pharmacological treatment of ocular development
US5122522A (en) *	1989-06-21	1992-06-16	The Trustees Of The University Of Pennsylvania	Treatment and control of ocular development
ATE147626T1 (de) *	1989-06-21	1997-02-15	Univ Pennsylvania	Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung
US5360801A (en) *	1989-06-21	1994-11-01	The Trustees Of The University Of Pennsylvania	Pharmacological stimulation of eye growth
US5055302A (en) *	1990-02-22	1991-10-08	Trustees Of The University Of Pennsylvania	Neuropeptide control of ocular growth
US5385939A (en) *	1993-04-30	1995-01-31	The Trustees Of The University Of Pennsylvania	GABA-ergic modulation of eye growth

1993
- 1993-04-30 US US08/056,056 patent/US5385939A/en not_active Expired - Lifetime
1994
- 1994-04-26 AT AT94914915T patent/ATE181829T1/de not_active IP Right Cessation
- 1994-04-26 ES ES94914915T patent/ES2136195T3/es not_active Expired - Lifetime
- 1994-04-26 EP EP94914915A patent/EP0701438B1/en not_active Expired - Lifetime
- 1994-04-26 CA CA002160798A patent/CA2160798C/en not_active Expired - Fee Related
- 1994-04-26 JP JP52448594A patent/JP3720047B2/ja not_active Expired - Fee Related
- 1994-04-26 WO PCT/US1994/004586 patent/WO1994025018A1/en not_active Ceased
- 1994-04-26 CN CN94191952A patent/CN1096854C/zh not_active Expired - Fee Related
- 1994-04-26 DK DK94914915T patent/DK0701438T3/da active
- 1994-04-26 AU AU67136/94A patent/AU6713694A/en not_active Abandoned
- 1994-04-26 DE DE69419416T patent/DE69419416T2/de not_active Expired - Fee Related
- 1994-09-27 US US08/313,356 patent/US5567731A/en not_active Expired - Lifetime
1999
- 1999-09-29 GR GR990402445T patent/GR3031352T3/el unknown

Also Published As

Publication number	Publication date
CA2160798C (en)	2005-07-12
EP0701438A4 (en)	1997-11-19
EP0701438B1 (en)	1999-07-07
JPH08509739A (ja)	1996-10-15
AU6713694A (en)	1994-11-21
US5567731A (en)	1996-10-22
US5385939A (en)	1995-01-31
CN1096854C (zh)	2002-12-25
DE69419416T2 (de)	1999-10-28
CA2160798A1 (en)	1994-11-10
CN1122104A (zh)	1996-05-08
ATE181829T1 (de)	1999-07-15
GR3031352T3 (en)	2000-01-31
DE69419416D1 (de)	1999-08-12
WO1994025018A1 (en)	1994-11-10
EP0701438A1 (en)	1996-03-20
ES2136195T3 (es)	1999-11-16
JP3720047B2 (ja)	2005-11-24

Similar Documents

Publication	Publication Date	Title
ATE20469T1 (de)	1986-07-15	Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
JPS52116465A (en)	1977-09-29	Peptides
DK0701438T3 (da)	1999-11-22	GABA'erg modulation af øjenvækst
LTIP711A (en)	1995-01-31	Remedies for phytotoxic side-effect
CA2134674A1 (en)	1993-11-25	Gaba and l-glutamic acid analogs for antiseizure treatment
IE810785L (en)	1981-10-18	Anti-inflammatory ophthalmic composition
KR850006187A (ko)	1985-10-02	신규 히달토인(Hydantoin) 유도체의 제조방법
EA199800121A1 (ru)	1998-08-27	Синергичная гербицидная композиция и способ ее применения
IE781148L (en)	1979-01-01	Ó-acetylenic derivatives of ó-amino acids.
ES8105969A1 (es)	1981-07-01	Procedimiento para preparar derivados fluorados de metil-be ta-alanina.
NZ335042A (en)	2001-01-26	Tranilast (N-(3,4-dimethoxycinnamoyl)anthranilic acid) as a secondary cataract inhibitor
ES8400109A1 (es)	1983-10-16	"un procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilico".
CA2137961A1 (en)	1995-06-17	Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites
IL133414A0 (en)	2001-04-30	Benzo (5, 6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
NZ222045A (en)	1989-10-27	From diamides up to tetrapeptides for use as anticanvulsants
BE899299A (fr)	1984-10-01	Composition fongicide a base de tris ethyl phosphonate d'aluminium
ES8504181A1 (es)	1985-04-01	Procedimiento para preparar nuevos derivados de piperidina
HUT53103A (en)	1990-09-28	Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
ATE158796T1 (de)	1997-10-15	Pharmazeutisch wirksame enantiomere
TW329388B (en)	1998-04-11	Intraocular irrigating solution
ES8301199A1 (es)	1982-12-01	Procedimiento para la preparacion de un derivado fluorado de diaminobutano que es enlubidor de transaminasa de acido gamma- aminobutirico.
ES2007598A6 (es)	1989-07-01	Composicion a base de derivados de fosfonatos amonicos y procedimientopara regular con ella el crecimiento de las plantas.
EP0897724A4 (en)	2003-05-07	MEDICINE AGAINST UVEITY
IE830147L (en)	1983-07-27	Hydroxyalkane diphosphonic acid derivatives
TW227527B (en)	1994-08-01	An aniline offshoot condenser's divergent agent and synthesizing method